Venture Capital in United Kingdom – Cambridge Research BioVentures

Cambridge Research BioVentures (CRB) is a technology investment fund established to support the early development of promising biomedical and life sciences discoveries. Research Corporation Technologies (RCT) of Tucson, Arizona has made £8 million available to the fund, to be invested exclusively in life science opportunities in the United Kingdom and Ireland. RCT is an independent technology management company that commercializes technologies from universities and research institutions throughout the world. RCT\'s commercialization vehicles include licensing, partnerships, seed investments and venture development of early-stage technologies. © Cambridge Research BioVentures